Relationship between the amniotic fluid prolactin level at early second trimester and pregnancy outcome

Year 2022, Volume: 5 Issue: 3, 715 - 719, 30.05.2022

Hicran Şirinoğlu Savaş Özdemir Oya Gökçer Simten Genç Cagdas Nurettin Emeklioglu Enis Özkaya

https://doi.org/10.32322/jhsm.1062655

Abstract

Aim: The aim of this study was to determine whether early second trimester amniotic fluid prolactin level were associated with pregnancy outcome.
Material and Method: This study included 125 women who underwent amniocentesis for variable indications. Healthy subjects with no history of drug use were included in this study. The gestational age was determined by ultrasonic examination before 10 weeks in all cases. Amniotic fluid specimens were taken while performing amniocentesis for other indications. Amniotic fluid was collected by transabdominal amniocentesis. Amniotic fluid prolactin concentrations were utilized to predict pregnancy complication among women who underwent amniocentesis due to the variable indications.
Results: Among all study population, pregnancy was unremarkable in 102 (81.6%) cases, on the other hand, most common fetal abnormality was found to be the fetal hydrops fetalis and the second most commonly encountered fetal anomaly was trisomy, intrauterine growth restriction and intrauterine fetal demise. All study population was divided into two groups as complicated (n=23) and uncomplicated (n=102) pregnancies. Amniotic fluid prolactin concentration did not have any predictive value for complicated pregnancies (AUC=0.479).
Conclusion: Our data showed; there is no relationship between early second trimester amniotic fluid prolactin level and pregnancy outcome.

Keywords

Decidual prolactin, pregnancy outcome, early second trimester

References

• Handwerger S, Richards RG, Markoff E. The physiology of decidual prolactin and other decidual protein hormones. Trends Endocrinol Metab 1992; 3: 91-5.
• Lopez-Vicchi F, De Winne C, Brie B, Sorianello E, Ladyman SR, Becu-VillalobosD. Metabolic functions of prolactin: Physiological and pathological aspects.J Neuroendocrinol 2020; 32: e12888.
• De Santis M, Cavaliere AF, Noia G, Masini L, Menini E, et al. Acute recurrent polyhydramnios and amniotic prolactin. Prenat Diagn 2000: 20: 347-8.
• Shaarawy M, El-Minawi AM. Prolactin and calcitropic hormones in preterm premature rupture of membranes. Int J Gynaecol Obstet 2004; 84: 200-7.
• Maaskant RA, Bogic LV, Gilger S, Kelly PA, Bryant-Greenwood GD. The human prolactin receptor in the fetal membranes, decidua, and placenta. J Clin Endocrinol Metab 1996; 81: 396-405.
• Fetal Growth Restriction: ACOG Practice Bulletin, Number 227
• Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida Nat Rev Dis Primers 2015; 1: 15007.
• Kontomanolis EN, Fasoulakis Z. Hydrops fetalis and the parvovirus B-19. Curr Pediatr Rev 2018; 14: 239-252.
• Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 76: 1690-702.
• Wu WX, Brooks J, Glasier AF, McNeilly AS. The relationship between decidualization and prolactin mRNA and production at different stages of human pregnancy. J Mol Endocrinol 1995; 14: 255-61.
• Root AW.Growth hormone and prolactin in the fetus. Prog Clin Biol Res 1976; 10: 107 -26
• Tyson JE, McCoshen JA, Dubin NH. Inhibition of fetal membrane prostaglandin production by prolactin: Relative importance in the initiation of labor. Am J Obstet Gynecol 1985; 151: 1032-8.
• Kletzky OA, Rossman F, Bertolli SI, Platt LD, Mishell DRJ. Dynamics of HCG, PRL, and growth hormone in serum and AFthroughout normal human pregnancy. Am J Obstet Gynecol 1985; 151: 878-84.
• Fang US, Kim MH. Study of maternal, fetal and amniotic human prolactin at term. J Clin Endocrinol Metab 1975; 41: 1030-4.
• Demir N, Celiloglu M, Thomassen PA, Onvural A, Erten O. Maternal, fetal and amniotic fluid prolactin levels in term and post-term pregnancies. Acta Obstet Gynecol Scand 1993; 72: 218-20.
• Ho Yuen B, Mincey EK. Human chorionic gonadotropin, prolactin, estriol and DHEAS concentrations in cord blood of premature and term newborn infants: Relationship to the sex of the neonate. Am J Obstet Gynecol 1987; 156: 396-400.
• Biswas S. Prolactin in amniotic fluid: Its correlation with maternal plasma prolactin. Clin Chim Acta 1976; 73: 363-7.
• Johnsten JM, Bleasdale JE, Hoffman DR. Functions of PAF in reproduction and development: Involvement of PAF in fetal lung maturation and parturition. In: Snyder F, ed. Platelet activating factor and related lipid mediators. New York, London: Plenum Press, 1987: 375-99.
• Leontic EA, Schruefer JJ, Andreassen B, et al. Further evidence for the role of prolactin on human fetoplacental osmoregulation. Am J Obstet Gynecol 1979: 133: 435.
• Leaños-Miranda A, Márquez-Acosta J, Cárdenas-Mondragón GM, et al. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab 2008; 93: 2492-9.
• Luciano AA, Varner MW. Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies. Obstet Gynecol 1984; 63: 384-8.
• Flores-Espinosa P, Vega-Sánchez R, Mancilla-Herrera I, et al. Prolactin selectively inhibits the LPS-induced chemokine secretion of human foetal membranes. J Matern Fetal Neonatal Med 2019: 1-7.
• Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19: 225-68.
• Luciano AA, Varner MW: Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies. Obstet Gynecol 1984; 63: 384-8.
• Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972; 113: 14-20.
• Kletzky OA, Rossman F, Bertolli SI, Platt LD, Mishell DR. Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and AF throughout normal human pregnancy. Am J Obstet Gynecol 1985; 151: 878-84.
• Rode L, Bundgaard A, Skibsted L, Odum L, Jørgensen C, Langhoff-Roos J. Acute recurrent polyhydramnios: a combination of amniocenteses and NSAID may be curative rather than palliative. Fetal Diagn Ther 2007; 22: 186-9.
• Mann SE, Nijland MJ, Ross MG: Mathematic modeling of human AFdynamics. Am J Obstet Gynecol 1996; 175: 937-944.
• Bujanover Y, Wollman Y, Reif S, Golander A. A possible role of prolactin on growth and maturation of the gut during development in the rat. J Pediatr Endocrinol Metab 2002; 15: 789-94.
• Tanaka S, Koibuchi N, Ohtake H, et al. Regional comparison of prolactin gene expression in the human decidualized endometrium in early and term pregnancy. Eur J Endocrinol 1996; 135: 177-83.
• Mazor M, Hershkowitz R, Ghezzi F, et al. Prolactin concentrations in preterm and term pregnancy and labour. Arch Gynecol Obstet 1996; 258: 69-74.